Prenatal diagnosis
Prenatal diagnosis
Audio Summaries
Every issue of Prenatal diagnosis moves the field forward, but reading every paper cover-to-cover isn't realistic. OSLR turns each article into a 3-minute audio summary so you can stay current while you commute, round, or work out.
Recent summaries
The latest articles summarized from Prenatal diagnosis.
Changes in Perinatal Management in Pregnancies With Abnormal Findings Detected on Ultrasound in the Late Second and Third Trimester.
Nov 19, 2026
This retrospective cohort study of 1,116 women referred for advanced fetal ultrasound in the late second or third trimester (in a setting without routine third-trimester screening) asked how often these referrals uncover abnormalities that change perinatal care. Abnormal findings were confirmed in 65% of cases, and hospital-led care rose from 38.9% to 69.4% after confirmation, with 20% of pregnancies ending in induction for the anomaly. The authors conclude that late-pregnancy findings frequently alter management and argue for offering all women a standardized third-trimester anatomical scan.
Phenotypic Severity Determines Overall Pregnancy Outcome and Survival in Fetuses With Turner Syndrome: Insights From a Large Multicenter Cohort.
Nov 18, 2026
This multicentre cohort of 726 prenatally diagnosed Turner syndrome pregnancies asked how survival varies by karyotype (45,X, mosaic, or structural X anomalies) and phenotypic severity. Mosaic and structural karyotypes carried a lower risk of intrauterine death than 45,X, but severe fetal structural abnormalities were the strongest predictor of mortality (HR 4.82), with minimal survival estimated at 9.6% for 45,X, 50.0% for mosaic, and 36.8% for structural variants. The authors conclude that phenotypic severity, more than karyotype alone, is the main determinant of pregnancy outcome and that survival is higher than historically reported.
Phenotype Before Genotype? The Order of Cell-Free DNA and the First-Trimester Scan in 11,270 Pregnancies.
Nov 17, 2026
This study asks whether the order of cell-free DNA (cfDNA) testing relative to the first-trimester ultrasound scan affects genetic screening decisions, and whether a positive result's meaning depends on the condition and the scan phenotype. Across 11,270 scanned pregnancies, cfDNA was drawn before the scan in 40.2% of cases, and in a chart review of high-NT pregnancies the sampling preceded phenotyping in 16 of 19 cases. Positive predictive value ranged from 95% for trisomy 21 to 17% for sex chromosome aneuploidies, and the authors conclude that test order did not change modelled referral eligibility but determined whether screening information came before the phenotype that establishes whether testing is needed.
Genetic Diagnoses and Postnatal Outcomes in a Prenatal Cohort of Arthrogryposis Multiplex Congenita.
Nov 15, 2026
This retrospective cohort study of 94 prenatally evaluated pregnancies with arthrogryposis multiplex congenita (AMC) asked what genetic causes underlie AMC and what postnatal outcomes follow. Next-generation sequencing identified a molecular diagnosis in 50% of pregnancies with non-diagnostic cytogenetic results, with single gene disorders being a frequent cause. Neonates with fetal akinesia deformation sequence had high mortality (86%), while most infants with isolated arthrogryposis survived but often needed respiratory, feeding, orthopedic, and developmental support, supporting broader use of NGS and highlighting high neonatal morbidity.
What Patients are Reading About Prenatal Cell-Free DNA: An Analysis of Leading Publicly Available AI-Chatbots.
Nov 14, 2026
This study qualitatively analyzed outputs from three publicly available AI chatbots about prenatal cell-free DNA (cfDNA) screening, generated under simulated user age profiles with steps taken to limit personalization. The authors asked whether these tools provide accurate, complete, and consistent patient-facing information. They found substantial variation across platforms and age profiles, including misinformation, omitted test limitations, screening-versus-diagnostic conflation, readability at a 9th-14th grade level, and few or no citations to high-quality sources.
Health Professionals' Preferences for Genetic Prenatal Testing-An International Discrete Choice Experiment Survey.
Nov 13, 2026
This study used an international discrete choice experiment to examine how healthcare professionals involved in genetic prenatal diagnostics weigh attributes of prenatal genomic testing after a fetal anomaly is detected, including their attitudes toward uncertain results. Diagnostic yield was ranked as the most important factor, and respondents favored tests with higher diagnostic yield and shorter turnaround times, with clinical geneticists showing more caution toward uncertainty than gynaecologists, who prioritized rapid results. The authors conclude that this cautious professional stance contrasts with prior findings from prospective parents, who generally wish to receive as much information as possible.
Measuring the Utility of Prenatal Exome Sequencing Using the Clinician-Reported Genetic Testing Utility InDEx for Prenatal Care: A Retrospective Multicentre Study.
Nov 11, 2026
This retrospective multicentre study of 115 Ontario pregnancies asked whether prenatal exome sequencing provides clinical utility, measured with the clinician-reported C-GUIDE Prenatal tool. The diagnostic yield was 41.7%, and informative positive results, meeting three or more ES criteria, and ongoing pregnancy at disclosure were each associated with higher utility scores. The findings help fill an evidence gap on the clinical value of prenatal genetic testing to inform policy and funding decisions.
The Content and Role of an Online Support Group for Parents of an Unborn Baby With a Diagnosis of Spina Bifida Considering Fetal Surgery: A Qualitative Analysis.
Nov 11, 2026
This qualitative study used thematic analysis of posts from a closed UK Facebook group to explore what concerns parents discuss when considering open fetal surgery for their unborn baby with spina bifida. The analysis identified three themes: maternal physical and psychological support, navigating ongoing child health and development, and decision-making and preparation for surgery. The authors conclude that parental concerns extend beyond what is covered in current pre-surgical counseling, and they recommend that clinicians provide additional information and support throughout pregnancy, surgery, and the child's ongoing care.
Sociodemographic Variation in Prenatal Aneuploidy Screening and First-Line Non-Invasive Prenatal Testing: A Multicentre Cohort Study.
Nov 11, 2026
This multicentre cohort study of 80,355 women giving birth in Melbourne public hospitals (2022-2024) examined how prenatal aneuploidy screening uptake and test modality vary across sociodemographic and clinical characteristics in a setting where NIPT is recommended but self-funded. NIPT was the most common modality (80.6% of screened women), but its uptake rose from 75.3% in the most disadvantaged areas to 88.9% in the most advantaged, a socioeconomic gradient that persisted after adjustment. The authors conclude that access to the most accurate screening test is unequal, with women in disadvantaged regions, along with younger, multiparous, and certain migrant women who declined screening, less likely to benefit.
Risk Factors for Seven Common Aneuploidies: Successes, Limitations, Missed and New Opportunities.
Nov 10, 2026
This review examines risk factors for seven common aneuploidies (autosomal trisomies, 47,XXY, and 47,XXX), asking how maternal age and family history should inform genetic counselling and screening, and what drives the unexplained recurrence risk. The authors conclude that hereditary predisposition, cryptic parental mosaicism, and environmental factors remain poorly understood, partly because pregnancy losses are rarely karyotyped and screening has complicated research. They argue that cell-free DNA screening, combined with population screening programs, birth defect registers, variant databases, and electronic health records, offers an opportunity to revive epidemiological approaches to aneuploidy origins.
